SWTX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- European Commission grants approval of OGSIVEO® (nirogacestat) for treatment of adults with desmoid tumorsAug 19, 2025
- European Commission grants conditional approval of EZMEKLY® (mirdametinib) for adults and children with NF1-PNJul 21, 2025
- SpringWorks Therapeutics receives positive CHMP opinion for Nirogacestat to treat adults with desmoid tumorsJun 20, 2025
- SpringWorks receives positive CHMP opinion on Mirdametinib for treating NF1-PN in adults and childrenMay 23, 2025